Dyslipidaemia associated with the highly active antiretroviral therapy in aids patient: reversion after switching (stavudine to tenofovir and lopinavir/ritonavir to atazanavir/ritonavir)
Antiretroviral therapy has been associated with hyperlipidemia in AIDS patients. This case illustrates the classic metabolic effects associated to the HAART including protease inhibitors and/or stavudine. It was showed that the management of the HAART-associated dyslipidaemia with conventional antihyperlipidemic therapy may fail, being the switching strategy the best option.
Saved in:
Main Authors: | Domingos,Hamilton, Cunha,Rivaldo Venâncio da, Paniago,Anamaria Mello Miranda |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Brazilian Society of Infectious Diseases
2007
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702007000200025 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recurrent oedema associated with the co-formulation of lopinavir and ritonavir
by: Pinto,Jorge Francisco C., et al.
Published: (2004) -
Ficha técnica RACIM : Lopinavir – Ritonavir (LPV/r)
by: Nuñez Montoya, Susana Carolina, et al.
Published: (2020) -
USE OF LOPINAVIR/RITONAVIR ASSOCIATED WITH ERGOTAMINE RESULTING IN FOOT AMPUTATION: BRIEF COMMUNICATION
by: Ferry,Fernando Raphael de Almeida, et al.
Published: (2014) -
Lopinavir/ritonavir dosing during pregnancy in Brazil and maternal/infant laboratory abnormalities
by: Peixoto,Mario Ferreira, et al.
Published: (2011) -
Factors associated with clinical, immunological and virological responses in protease-inhibitor-experienced brazilian children receiving highly active antiretroviral therapy containing Lopinavir-Ritonavir
by: Machado,Daisy Maria, et al.
Published: (2007)